Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term effect and safety of mesenchymal stromal cell therapy for radiation-induced hyposalivation in head and neck cancer survivors: A randomised, phase-2, trial.
Fenger Carlander AL, Jakobsen KK, Todsen T, Paaske N, Østergaard Madsen AK, Bendtsen SK, Kastrup J, Friborg J, Duch Lynggaard C, Hauge AW, Christensen R, Grønhøj C, von Buchwald C. Fenger Carlander AL, et al. Among authors: paaske n. Clin Cancer Res. 2025 Jan 3. doi: 10.1158/1078-0432.CCR-24-2663. Online ahead of print. Clin Cancer Res. 2025. PMID: 39751638
Optical molecular imaging in oral- and oropharyngeal squamous cell carcinoma using a novel uPAR-targeting near-infrared imaging agent FG001 (ICG-Glu-Glu-AE105): An explorative phase II clinical trial.
Andersen AO, Christensen A, Straede K, Lawaetz M, Hahn CH, Rubek N, Wessel I, Lelkaitis G, Kiss K, Paaske N, Poulsen A, von Buchwald C, Kjaer A. Andersen AO, et al. Among authors: paaske n. Theranostics. 2025 Jan 1;15(1):52-67. doi: 10.7150/thno.100042. eCollection 2025. Theranostics. 2025. PMID: 39744227 Free PMC article. Clinical Trial.
Mesenchymal Stem/Stromal Cell Therapy for Radiation-Induced Xerostomia in Previous Head and Neck Cancer Patients: A Phase II Randomized, Placebo-Controlled Trial.
Jakobsen KK, Carlander AF, Todsen T, Melchiors J, Paaske N, Østergaard Madsen AK, Kloch Bendtsen S, Mordhorst C, Stampe H, Kastrup J, Ekblond A, Haack-Sørensen M, Farhadi M, Maare C, Friborg J, Lynggaard CD, Werner Hauge A, Christensen R, Grønhøj C, von Buchwald C. Jakobsen KK, et al. Among authors: paaske n. Clin Cancer Res. 2024 May 15;30(10):2078-2084. doi: 10.1158/1078-0432.CCR-23-3675. Clin Cancer Res. 2024. PMID: 38441659 Free PMC article. Clinical Trial.
Effectiveness and safety of mesenchymal stem/stromal cell for radiation-induced hyposalivation and xerostomia in previous head and neck cancer patients (MESRIX-III): a study protocol for a single-centre, double-blinded, randomised, placebo-controlled, phase II study.
Jakobsen KK, Carlander AF, Grønhøj C, Todsen T, Melchiors J, Paaske N, Madsen AKØ, Kastrup J, Ekblond A, Haack-Sørensen M, Farhadi M, Maare C, Friborg J, Lynggard CD, von Buchwald C. Jakobsen KK, et al. Among authors: paaske n. Trials. 2023 Sep 1;24(1):567. doi: 10.1186/s13063-023-07594-5. Trials. 2023. PMID: 37658468 Free PMC article.